Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3501597013 | Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3676787012 | Product containing precisely aspirin 325 milligram and carisoprodol 200 milligram and codeine phosphate 16 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4722731000005119 | acetylsalicylsyre 325 mg + carisoprodol 200 mg + codeinphosphat 16 mg tablet | da | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | dansk modul |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Is a | kombinationspræparat med acetylsalicylsyre | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Is a | codeinphosphatprodukt | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Codeine phosphate | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Morphinan opioid | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Aspirin (substance) | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Codeine (substance) | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Is a | acetylsalicylsyre + carisoprodol + codeinphosphat | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Carisoprodol (substance) | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Is a | Product containing aspirin in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Is a | Codeine-containing product in oral dose form | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has basis of strength substance (attribute) | Carisoprodol (substance) | false | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength denominator value | en | false | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength denominator value | en | false | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength denominator value | en | false | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Carisoprodol (substance) | false | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has basis of strength substance (attribute) | Carisoprodol (substance) | false | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Codeine phosphate | false | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has basis of strength substance (attribute) | Codeine phosphate | false | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator value | 16 | false | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has basis of strength substance (attribute) | Aspirin (substance) | true | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator value | 325 | false | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has active ingredient | Aspirin (substance) | false | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has basis of strength substance (attribute) | Aspirin (substance) | false | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator value | 325 | false | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has precise active ingredient | Carisoprodol (substance) | false | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has precise active ingredient | Codeine phosphate | false | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Is a | Aspirin- and carisoprodol- and codeine-containing product in oral dose form | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has precise active ingredient | Aspirin (substance) | true | Inferred relationship | Some | 3 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Count of base of active ingredient | tre | false | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Is a | Aspirin and carisoprodol and codeine only product in oral dose form | true | Inferred relationship | Some | ||
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has precise active ingredient | Codeine phosphate | true | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has basis of strength substance (attribute) | Codeine phosphate | true | Inferred relationship | Some | 1 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has basis of strength substance (attribute) | Carisoprodol (substance) | true | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has precise active ingredient | Carisoprodol (substance) | true | Inferred relationship | Some | 2 | |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Plays role | Antitussive therapeutic role (role) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets